Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
Substudy 01A is part of a larger research study that is testing experimental treatments for metastatic castration-resistant prostate cancer (mCRPC). The larger study is the umbrella study (U01). The goal of substudy 01A is to evaluate the safety and efficacy of opevesostat-based treatment combinations, or as a single agent, in participants with mCRPC. This substudy will have two phases: a safety lead-in phase and an efficacy phase. The safety lead-in phase will be used to evaluate the safety a
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this prostate cancer clinical trial in Baltimore, MD
If you're searching for prostate cancer treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.